IMPACT OF RITUXIMAB ON IMMUNE STATUS FOLLOWING THERAPY IN CHILDREN AND ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN LYMPHOMA: RESULTS OF THE INTER-B-NHL RITUX 2010 TRIAL

被引：0
|
作者：
Alexander, S. [1 ]
Auperin, A. [2 ]
Bomken, S. [3 ]
Csoka, M. [4 ]
Kazanowska, B. [5 ]
Chiang, A. [6 ]
Andres Moreno, M. [7 ]
Uyttebroeck, A. [8 ]
Burke, A. [9 ]
Zsiros, J. [10 ]
Pillon, M. [11 ]
Bollard, C. [12 ,13 ]
Barkauskas, D. [14 ]
Wheatley, K. [15 ]
Patte, C. [16 ,17 ]
Gross, T. [18 ]
Minard-Colin, V. [16 ,17 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[2] Univ Paris Saclay, Unit Biostat & Epidemiol, Gustave Roussy, Villejuif, France
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Paediat Haematol & Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Semmelweis Univ, Dept Pediat Hematol & Oncol, Budapest, Hungary
[5] Wroclaw Med Univ, Dept Pediat Bone Marrow Transplantat Oncol & Hema, Wroclaw, Poland
[6] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Peoples R China
[7] Univ Valencia, Dept Pediat Hematol & Oncol, Valencia, Spain
[8] Univ Hosp Leuven, Dept Pediat Hematol & Oncol, Leuven, Belgium
[9] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Paediat Haematol Oncol & Palliat Care, Cambridge, England
[10] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[11] Univ Padua, Dept Pediat Hematol & Oncol, Padua, Italy
[12] George Washington Univ, Ctr Canc & Immunol Res, Washington, DC USA
[13] George Washington Univ, Washington, DC USA
[14] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA
[15] Royal Marsden NHS Fdn Trust, Dept Histopathol, London, England
[16] Univ Paris Saclay, Gustave Roussy, Dept Pediat, Villejuif, France
[17] Univ Paris Saclay, Gustave Roussy, Dept Adolescent Oncol, Villejuif, France
[18] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA
来源：
LEUKEMIA RESEARCH | 2022年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
011
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [21] Total IgE serum levels and risk of mature B cell non-Hodgkin lymphoma (NHL)
    Levin, Lynn I.
    Breen, Elizabeth C.
    Kitchen, Christina R.
    Kim, Bong K.
    Magpantay, Larry I.
    Martinez-Maza, Otoniel
    CANCER RESEARCH, 2011, 71
  • [22] Comprehensive analysis of relapsed-refractory mature B-cell non-Hodgkin lymphoma in children and adolescents
    Mato, Sara
    Carita, Lorenzo
    Colmenero, Ariadna
    Andres, Mara
    Balague, Olga
    Andion, Maitane
    Astigarraga, Itziar
    Celis, Veronica
    Mendoza, Carmen
    Guerra-Garcia, Pilar
    Valero, Lorena
    Galera, Ana
    Tallon, Maria
    Pol, Melina
    Castrejon-de-Anta, Natalia
    Frauenfeld, Leonie
    Garcia, Noelia
    Campo, Elias
    Salaverria, Itziar
    Verdu-Amoros, Jaime
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
  • [23] TANDEM AUTOLOGOUS ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED/REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Gardenswartz, A.
    Mehta, B.
    El-Mallawany, N.
    van de Ven, C.
    Hochberg, J.
    Flower, A.
    Morris, E.
    Harrison, L.
    Basso, J.
    Gerard, P.
    Ayello, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [24] Disruption of the SUMO Pathway in a High-Risk B-Cell Non-Hodgkin Lymphoma Pedigree
    Garner, Cassandra
    Glenn, Martha
    Waller, Rosalie G.
    Rajamanickam, Venkatesh
    Darlington, Todd
    Sargent, Rob
    Camp, Nicola J.
    BLOOD, 2015, 126 (23)
  • [25] Evaluation of Epcoritamab and Rituximab Combination in Preclinical Models of B-Cell Non-Hodgkin's Lymphoma (NHL)
    Epling-Burnette, P. K.
    Dandamudi, Durga B.
    Konieczna, Iwona M.
    Calabrese, Kelly M.
    Wielgos-Bonvallet, Monica
    Kweekel, Christiaan
    Gresnigt-van den Heuvel, Elke
    Parikh, Apurvasena
    Li, Tommy
    Chiu, Christopher W.
    Chervin, Adam
    Reilly, Edward B.
    Szafer-Glusman, Edith
    BLOOD, 2022, 140 : 9283 - 9285
  • [26] Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma in Children, Adolescents, and Young Adults
    Gardenswartz, Aliza
    Cairo, Mitchell S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (05):
  • [27] RITUXIMAB IN THERAPY OF PERIPHERAL B-CELL NON-HODGKIN'S LYMPHOMAS IN CHILDREN
    Valiev, T. T.
    Morozova, O. V.
    Makhonova, L. A.
    Mentkevich, G. L.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2010, 55 (03): : 13 - 16
  • [28] Dosimetry results of Oncolym™ in the treatment of refractory B-cell non-Hodgkin's lymphoma (NHL).
    Verkh, LI
    Murray, JL
    Kripas, CJ
    Wessels, BW
    Varma, VM
    Kahn, D
    Bushnell, DL
    Serafini, AN
    Oliver, JC
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (01) : 66 - 66
  • [29] Effect of body mass index on the prognosis of children and adolescents with high-grade mature B-cell non-Hodgkin lymphoma
    Zeng, Chenggong
    Wei, Zhiqing
    Huang, Junting
    Zhu, Jia
    Sun, Feifei
    Wang, Juan
    Lu, Suying
    Zhang, Yizhuo
    Sun, Xiaofei
    Zhen, Zijun
    CANCER, 2024, 130 (23) : 4109 - 4117
  • [30] Patient parameters and response after administration of rituximab in pediatric mature B-cell non-Hodgkin lymphoma
    Bethke, Maria
    Varga, Georg
    Weinhage, Toni
    Sabharwal, Harshana
    Mellgren, Karin
    Randau, Gerrit
    Rolfing, Meike
    Wittkowski, Helmut
    Foell, Dirk
    Michgehl, Ulf
    Burkhardt, Birgit
    PEDIATRIC BLOOD & CANCER, 2022, 69 (04)
12345